Skip to content
★ Sign in to follow
TH

Tobias Hägglöv

Recipharm AB
Total declarations
13
Company
1
▲ Purchases (10 ops.)
€87k
▼ Sales (3 ops.)
€134k

Latest filing published 17 Feb 2021 for Recipharm AB, €44k.

Filing timeline

BuySale
Tobias Hägglöv

Insider track record

Disclosed buys
10
Disclosed sells
3
Signal history

Closed purchases

Market purchases
10

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Tobias Hägglöv: trading record in brief

Tobias Hägglöv appears in our data through filings on Recipharm AB shares, published by Finansinspektionen. We count 13 filings; the first trade dates from 22 February 2019 and the latest from 15 February 2021.

Both buying and selling appear: 10 purchases worth €87k, against 3 sales worth €134k. Taken together, the sales exceed the purchases by €47k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2021, the count stands at no purchases and 2 sales.

The median purchase comes to €6,253. 4 out of 9 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 17 February 2021, the filings show an open-market sale worth €44k in Recipharm AB. The most recent open-market purchase was published on 17 November 2020, 2,182 days ago. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 2 days. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Tobias Hägglöv

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations13 total
  • ▼
    Ekonomichef/finanschef/finansdirektörExecutivesRecipharm AB
    440,800 SEK39FI-SE
    1,900 shares@ SEK 232.0019.8% of flowAktieFI:csv-771e974dbbfceef4390a
  • ▼
    Ekonomichef/finanschef/finansdirektörExecutivesRecipharm AB
    496,712 SEK27FI-SE
    2,141 shares@ SEK 232.00100.0% of flowAktieISIN SE0005757267FI:A001Q230-1
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesRecipharm AB
    80,001 SEK19FI-SE
    526.325 shares@ SEK 152.004.4% of flowAktieISIN SE0005757267FI:csv-e20c27b1c969244f51ad
    Canonical exit: 10 Feb 2021 (T+90)
  • ▲
    Ekonomi/finanschefExecutivesRecipharm AB
    37,800 SEK0FI-SE
    269.902 shares@ SEK 140.052.1% of flowAktieISIN SE0005757267FI:csv-515f829f66e247a58235
    Canonical exit: 27 Oct 2020 (T+90)
  • ▼
    Ekonomi/finanschefExecutivesRecipharm AB
    420,600 SEK21FI-SE
    3,000 shares@ SEK 140.2023.0% of flowAktieISIN SE0005757267FI:csv-9345e26e338d9c7d4594
  • ▲
    Ekonomi/finanschefExecutivesRecipharm AB
    98,000 SEK32FI-SE
    1,400 shares@ SEK 70.005.2% of flowAktieISIN SE0005757267FI:csv-174c9374b8d2b2f0719e
    Canonical exit: 20 Sept 2020 (T+90)
  • ▲
    Ekonomi/finanschefExecutivesRecipharm AB
    37,650 SEK31FI-SE
    537.852 shares@ SEK 70.002.0% of flowAktieISIN SE0005757267FI:csv-d50e5d8a33c38a7a7a9f
    Canonical exit: 20 Sept 2020 (T+90)
  • ▲
    Ekonomi/finanschefExecutivesRecipharm AB
    159,000 SEK20FI-SE
    1,500 shares@ SEK 106.0012.0% of flowAktieISIN SE0005757267FI:csv-180e0bb893d77c642a72
    Canonical exit: 13 Aug 2020 (T+90)
  • ▲
    Ekonomi/finanschefExecutivesRecipharm AB
    56,700 SEK19FI-SE
    437.108 shares@ SEK 129.71624.3% of flowAktieISIN SE0005757267FI:csv-f812f0da361ae4384d27
    Canonical exit: 6 Aug 2020 (T+90)
  • ▲
    Ekonomi/finanschefExecutivesRecipharm AB
    56,700 SEK19FI-SE
    439.015 shares@ SEK 129.15284.3% of flowAktieISIN SE0005757267FI:csv-0c536ccb6c9faefa8316
    Canonical exit: 6 Aug 2020 (T+90)
  • ▲
    Ekonomi/finanschefExecutivesRecipharm AB
    56,700 SEK19FI-SE
    362.03 shares@ SEK 156.61673.0% of flowAktieISIN SE0005757267FI:csv-55993d8d988a993832f1
    Canonical exit: 21 May 2020 (T+90)
  • ▲
    Ekonomi/finanschefExecutivesRecipharm AB
    75,600 SEK31FI-SE
    545.49 shares@ SEK 138.59024.0% of flowAktieISIN SE0005757267FI:csv-8750c7bba23a99be8bdc
    Canonical exit: 25 Feb 2020 (T+90)
  • ▲
    Ekonomi/finanschefExecutivesRecipharm AB
    261,200 SEK32FI-SE
    2,000 shares@ SEK 130.6013.9% of flowAktieISIN SE0005757267FI:csv-6a30d0c640500a79bd74
    Canonical exit: 23 May 2019 (T+90)

13 of 13 declarations